Curious about what’s new in the world of myelodysplastic syndromes (MDS)? We’re bringing you the latest insights straight from one of the field’s leading experts.
In this episode, we speak with Dr. Mikkael Sekeres, of the Sylvester Comprehensive Cancer Center at University of Miami Health. Recorded onsite at the 2025 ASH (American Society of Hematology) Annual Meeting and Exposition, this conversation explores what MDS is, how it’s treated today, and what researchers are learning about managing side effects.
Dr. Sekeres also walks us through the most notable MDS updates presented at ASH, highlighting promising therapies and clinical trial data that may help shape future care. Whether you’re newly learning about MDS or following ongoing research, this episode offers an accessible look at where things stand and what’s on the horizon.
*This is not an official program of the ASH annual meeting
Podcast: Play in new window | Download
Subscribe: Spotify | Pandora | Blubrry | Podchaser | More
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Myelodysplastic syndromes
- International Prognostic Scoring System for MDS
- American Society of Hematology
- Highlights from ASH vlog
- Blood cancer research 2026: Meeting patients where they want to be | blog post
Additional Blood Cancer United Support Resources:
- Free Nutrition Consultations
- Information Specialists
- Financial support
- Clinical Trial Support Center
- Online Chat
- Free telephone/web patient programs
- Free booklets
- Young Adult Resources
- Support groups
- Caregiver support
- Caregiver Workbook
- Survivorship Workbook
- Advocacy and Public Policy
- Patient Community
- Mental Health Resources
Episode supported by Geron Corporation and Taiho Oncology, Inc.